Citius Oncology (CTOR) vs Telomir Pharmaceuticals (TELO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Telomir Pharmaceuticals (TELO) has outperformed Citius Oncology (CTOR) over the past year, losing 37.8% versus a loss of 54.7%. Citius Oncology is the larger company by market cap ($89.1 million vs $81.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTOR | TELO |
|---|---|---|
| Share price | $0.8429 | $1.11 |
| Market cap | $89.14M | $81.72M |
| 1-day change | -1.53% | -0.89% |
| YTD return | -14.90% | -15.79% |
| 1-year return | -54.73% | -37.78% |
| EPS (TTM) | $-0.48 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $2.09 |
| 52-week low | $0.491 | $0.888 |
| Distance from 52-week high | -62.54% | -46.92% |
| Average volume | 99.72K | 97.37K |
| Shares outstanding | 105.76M | 73.62M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TELO has outperformed CTOR by 17.0 percentage points over the past year.
CTOR vs TELO FAQ
Which is bigger, Citius Oncology or Telomir Pharmaceuticals?
Citius Oncology (CTOR) is larger, with a market capitalization of $89.14M compared with $81.72M for Telomir Pharmaceuticals (TELO).
Which stock has performed better over the past year, CTOR or TELO?
TELO returned -37.78% over the past 12 months, compared with -54.73% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Citius Oncology and Telomir Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.